APA (7th ed.) Citation

Inoue, M., Hayashi, A., Taguchi, T., Arai, R., Sasaki, S., Takano, K., . . . Shichiri, M. (2019). Effects of canagliflozin on body composition and hepatic fat content in type 2 diabetes patients with non‐alcoholic fatty liver disease. Journal of diabetes investigation, 10(4), 1004-1011. https://doi.org/10.1111/jdi.12980

Chicago Style (17th ed.) Citation

Inoue, Mitsuko, Akinori Hayashi, Tomomi Taguchi, Riina Arai, Sayaka Sasaki, Koji Takano, Yusuke Inoue, and Masayoshi Shichiri. "Effects of Canagliflozin on Body Composition and Hepatic Fat Content in Type 2 Diabetes Patients with Non‐alcoholic Fatty Liver Disease." Journal of Diabetes Investigation 10, no. 4 (2019): 1004-1011. https://doi.org/10.1111/jdi.12980.

MLA (9th ed.) Citation

Inoue, Mitsuko, et al. "Effects of Canagliflozin on Body Composition and Hepatic Fat Content in Type 2 Diabetes Patients with Non‐alcoholic Fatty Liver Disease." Journal of Diabetes Investigation, vol. 10, no. 4, 2019, pp. 1004-1011, https://doi.org/10.1111/jdi.12980.